TrueBlue, Inc. TBI
9.44
(0.09)
(0.94%)
as of 25 Sep
- Market cap
- $290.1M
- P/E
- 0.0×
Follow TBI
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.12 | 0.08 | 0.07 | 0.13 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(9.27) | (31.09) | (12.05) | (10.30) | |
P/B ratio |
0.60 | 0.49 | 0.46 | 0.83 | |
Price to Tangible BV |
0.75 | 0.63 | 0.59 | 1.07 | |
EV/Sales |
0.15 | 0.12 | 0.11 | 0.17 | |
EV/EBITDA |
204.85 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(5.12) | (3.26) | (3.93) | (5.20) | |
EV/FCF |
(3.73) | (2.57) | (3.02) | (4.20) | |
Quick Ratio |
1.75 | 1.92 | 1.89 | 2.10 | |
Current Ratio |
2.01 | 2.15 | 2.09 | 2.28 | |
Net Debt/EBITDA |
6.71 | (1.86) | (6.80) | 10.47 | |
Debt/Assets |
9.88% | 10.30% | 11.91% | 13.23% | |
Debt/Equity |
0.22 | 0.24 | 0.29 | 0.32 | |
Asset Turnover |
2.27 | 2.46 | 2.50 | 2.61 | |
Operating CF/Net income |
10.32 | 0.14 | 0.49 | 6.11 | |
Capex/Depreciation |
(0.49) | (0.43) | (0.27) | (0.50) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
21.27% | 22.70% | 21.90% | 18.92% | |
Intangible Assets out of Total Assets |
0.09 | 0.09 | 0.09 | 0.09 | |
Share Based Compensation of Revenue |
0.28% | 0.39% | 0.45% | 0.46% | |
Graham Net Nets |
(0.40) | (0.49) | (0.54) | (0.24) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(15.42%) | (35.06%) | (45.41%) | (26.97%) | |
Free Cash Flow Yield |
(35.67%) | (54.28%) | (50.51%) | (31.81%) | |
Revenue per Share |
14.43 | 14.01 | 13.22 | 14.57 | |
Operating CF per Share |
(0.66) | (0.15) | (0.32) | (0.68) | |
Capex per Share |
(0.12) | (0.10) | (0.09) | (0.11) | |
Free Cash Flow per Share |
(0.78) | (0.25) | (0.42) | (0.79) | |
Cash per Share |
0.67 | 0.82 | 0.80 | 0.76 | |
Shareholders Equity per Share |
10.18 | 9.20 | 8.50 | 8.37 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
10.18 | 9.20 | 8.50 | 8.37 | |
Free Cash Flow |
(23.38) | (7.49) | (12.61) | (23.95) | |
Working Capital |
157.54 | 159.08 | 157.43 | 178.99 | |
Capital Expenditures |
(3.62) | (3.13) | (2.83) | (3.37) | |
Net Current Asset Value |
(72.95) | (66.50) | (63.29) | (49.94) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
(0.44%) | (7.54%) | (4.97%) | (0.76%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
244.71 | 232.44 | 236.97 | 249.49 | |
Average Payables |
37.61 | 40.86 | 38.92 | 34.39 | |
Average Assets |
696.45 | 657.02 | 656.57 | 647.87 | |
Average Common Equity |
315.75 | 294.96 | 279.15 | 279.93 |
Columns are period end dates